HYPERTRIGLYCERIDEMIA THERAPEUTICS MARKET ANALYSIS

Regional Analysis

Global Hypertriglyceridemia Therapeutics Market- Regional Analysis

Among region, North America is estimated to hold a dominant position in the global hypertriglyceridemia therapeutics market over the forecast period owing to the increase prevalence of CVD such as coronary artery disease and atherosclerosis. For instance, on May 15, 2023, according to the CDC in U.S, coronary heart disease (CHD) is the most common type of heart disease, affecting about 375,476 people in 2021. About 1 in 20 adults age 20 and older have CAD (about 5%) and about 2 in 10 deaths from CAD happen in adults less than 65 years old.

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC Countries, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa